Capital Performance Advisors LLP Ocular Therapeutix, Inc Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Capital Performance Advisors LLP holds 8,034 shares of OCUL stock, worth $83,473. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,034Holding current value
$83,473% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding OCUL
# of Institutions
157Shares Held
139MCall Options Held
86.4KPut Options Held
263K-
Summer Road LLC West Palm Beach, FL14.9MShares$155 Million98.56% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$133 Million9.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$132 Million2.86% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.61MShares$89.5 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $800M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...